跳至主要内容
临床试验/NCT05972694
NCT05972694
已完成
不适用

The Effect of Grapes in Inflammatory Bowel Disease

Case Western Reserve University2 个研究点 分布在 1 个国家目标入组 21 人2024年9月16日

概览

阶段
不适用
干预措施
Freeze dried grape powder
疾病 / 适应症
Crohn Disease
发起方
Case Western Reserve University
入组人数
21
试验地点
2
主要终点
fecal microbiota composition
状态
已完成
最后更新
上个月

概览

简要总结

The overall objective of this pilot intervention study is to determine the impact of grape powder (46g/day freeze dried whole grape powder provided by the California Table Grape Commission) on the gut microbiotacomposition in adult patients with the IBD subtype Crohn's disease (CD).

详细描述

This protocol is designed to investigate the effect of grape powder consumption in Inflammatory Bowel Disease (IBD), in particular how grape powder consumption (provided as 46g/day grape powder; equivalent to 1.5 cups fresh grapes) alters the gut microbiota (GM) composition in humans with IBD. The investigators will focus on studying IBD patients affected with CD as a proof of principle that could be tested later in other IBD subtype (ulcerative colitis or others specific surgical conditions). The overall objective of this pilot intervention study is to determine the impact of grape powder (46g/day freeze dried whole grape powder provided by the California Table Grape Commission) on the GM composition in adult patients with the IBD subtype Crohn's disease (CD). An 28 day pilot study in adult CD patients at the Digestive Health Institutes (DHI) of University Hospitals Cleveland Medical Center (UHCMC). table Participation in this study will last for a maximum of 28 days and will consist of two phases. Phase I (baseline period - 7 days) where all grapes and berries will be removed from the diet, and Phase II (intervention period - 21 days) where participants will be supplemented with 46g/d freeze-dried grape powder consumed as 22.5g packets twice daily. The dose of 46g/day of grape powder is equivalent to 1.5 cups of grapes. Participants will be asked to avoid consumption of all other grapes/berries during phase II. The investigators will compare the before and after changes in gut microbiota composition.

注册库
clinicaltrials.gov
开始日期
2024年9月16日
结束日期
2026年2月15日
最后更新
上个月
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Documented diagnosis of Crohns disease. CD outpatients in remission
  • Harvey Bradshaw-index in remission (\<6 score)
  • Capable of providing consent to participate.
  • Able to complete daily surveys and take oral nutrition
  • Able to record daily meal intake

排除标准

  • Short bowel syndrome.
  • Hospitalized patients.
  • Individuals who lack consent capacity, including the mentally ill, prisoners, cognitively impaired participants, dementia patients.
  • Known drug abuse.
  • Known parasitic disease of the digestive system.
  • Symptomatic intestinal stricture.
  • Presence of an ostomy.
  • Other conditions that would be a contraindication to consumption of the study diets or preclude the participant from completing the study.
  • Well-founded doubt about the patients cooperation.
  • Existing pregnancy or lactation.

研究组 & 干预措施

Freeze-dried Grape powder intervention

participants will be supplemented with 46g/d freeze-dried grape powder consumed as 22.5g packets twice daily for 21 days.

干预措施: Freeze dried grape powder

结局指标

主要结局

fecal microbiota composition

时间窗: baseline (pre-intervention), immediately after the intervention

16S microbiome

次要结局

  • fecal calprotectin(baseline (pre-intervention), immediately after the intervention)
  • C-reactive protein (CRP)(baseline (pre-intervention), immediately after the intervention)
  • fecal myleoperoxidase (MPO)(baseline (pre-intervention), immediately after the intervention)

研究点 (2)

Loading locations...

相似试验